Crinetics Pharmaceuticals reported total assets of $1321.88M and total liabilities of $129.92M for the quarter ended Jun 2026, up 2.5% year over year. This balance sheet covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 3.25M | 3.48M | 3.72M | 3.94M | 3.81M | 4.08M | 4.37M | 4.60M | 4.88M | 5.07M | 5.48M | 6.23M | 6.98M | 7.73M | 8.64M | 9.59M | |||||||||||||||||||
| Receivables - AccuredAcc. Int. Receivables | 1.40M | 3.10M | 8.30M | 7.20M | 8.40M | 6.30M | 7.80M | 9.00M | 9.60M | ||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 161.54M | 201.19M | 145.55M | 62.29M | 30.91M | 33.97M | 41.19M | 39.55M | 142.79M | 54.90M | 395.92M | 302.16M | 317.27M | 264.55M | 94.57M | 53.73M | 110.90M | 101.54M | 114.34M | 55.50M | |||||||||||||||
| Receivables - NetNet Receivables | 0.59M | 5.68M | 11.96M | ||||||||||||||||||||||||||||||||
| Receivables - OtherOther Receivables | 0.09M | 0.55M | 0.62M | 1.16M | 1.40M | 1.35M | 1.27M | 0.90M | 2.62M | 3.05M | 3.17M | 3.48M | 3.37M | 8.31M | 7.22M | 8.38M | 6.34M | 7.76M | 8.96M | 9.57M | |||||||||||||||
| Receivables | 8.31M | 8.35M | 14.64M | 21.52M | |||||||||||||||||||||||||||||||
| Work In Process | 2.00M | 3.04M | 2.58M | ||||||||||||||||||||||||||||||||
| Finished Goods | 0.02M | 0.03M | 0.90M | ||||||||||||||||||||||||||||||||
| Inventory | 2.02M | 3.06M | 3.49M | ||||||||||||||||||||||||||||||||
| Prepaid Assets | 10.65M | 11.01M | 8.52M | 7.78M | 9.96M | 10.76M | 9.28M | 20.28M | 21.11M | 15.60M | 16.27M | 11.82M | 14.92M | 23.65M | 16.43M | 20.40M | 46.92M | 40.17M | 47.18M | 47.69M | |||||||||||||||
| Current Assets | 203.97M | 344.72M | 328.25M | 416.29M | 378.32M | 345.18M | 305.40M | 284.81M | 575.76M | 574.15M | 917.23M | 874.78M | 877.59M | 1,375.39M | 1,291.06M | 1,217.26M | 1,121.28M | 1,048.34M | 1,322.41M | 1,244.36M | |||||||||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 2.90M | 2.83M | 2.67M | 3.15M | 3.56M | 3.50M | 3.27M | 3.22M | 9.76M | 10.88M | 11.87M | 12.25M | 11.71M | 12.07M | 12.63M | 14.67M | 14.38M | 14.30M | 13.50M | 13.07M | |||||||||||||||
| Long-Term Deferred Tax | 194.68M | 291.54M | |||||||||||||||||||||||||||||||||
| Other Non-Current Assets | 0.50M | 0.50M | 0.50M | 0.50M | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 1.30M | 2.83M | 1.30M | 1.30M | 18.43M | 22.33M | 24.82M | 24.54M | |||||||||||||||
| Non-Current Assets | 5.39M | 6.29M | 5.04M | 5.45M | 6.56M | 6.99M | 8.61M | 8.44M | 65.78M | 61.20M | 60.92M | 60.76M | 59.79M | 59.20M | 70.27M | 72.31M | 74.76M | 77.92M | 78.91M | 77.52M | |||||||||||||||
| Assets | 209.36M | 351.01M | 333.29M | 421.73M | 384.88M | 352.18M | 314.01M | 293.25M | 641.54M | 635.35M | 978.15M | 935.53M | 937.37M | 1,434.59M | 1,361.33M | 1,289.57M | 1,196.03M | 1,126.26M | 1,401.32M | 1,321.88M | |||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||||||||
| Accounts Payables | 6.15M | 8.47M | 12.13M | 17.13M | 13.49M | 15.35M | 16.30M | 20.82M | 21.93M | 23.20M | 28.68M | 24.00M | 18.27M | 21.47M | 31.62M | 38.09M | 33.67M | 41.77M | 37.49M | 42.44M | |||||||||||||||
| Payables | 6.15M | 8.47M | 12.13M | 17.13M | 13.49M | 15.35M | 16.30M | 20.82M | 21.93M | 23.20M | 28.68M | 24.00M | 18.27M | 21.47M | 31.62M | 38.09M | 33.67M | 41.77M | 37.49M | 42.44M | |||||||||||||||
| Accumulated Expenses | 5.38M | 6.59M | 4.45M | 5.45M | 7.72M | 9.08M | 6.83M | 8.60M | 12.88M | 14.52M | 14.83M | 20.38M | 26.19M | 28.89M | 16.61M | 21.80M | 32.40M | 35.58M | 25.79M | 29.22M | |||||||||||||||
| Other Accumulated Expenses | 0.91M | 0.94M | 0.96M | 1.77M | 0.43M | 0.34M | 0.98M | 0.52M | 0.99M | 3.27M | 0.49M | 1.08M | 0.51M | 0.90M | 1.67M | 1.80M | |||||||||||||||||||
| Current Leases | 0.94M | 1.02M | 1.05M | 1.08M | 1.11M | 3.99M | 4.17M | 5.79M | 7.45M | 7.41M | 7.15M | 6.88M | 6.61M | 6.44M | 6.49M | 6.54M | 6.58M | ||||||||||||||||||
| Current Deferred Revenue | 2.71M | 2.54M | 2.32M | 2.24M | 2.12M | 2.08M | 1.66M | 2.06M | 2.46M | 2.56M | 1.69M | 2.18M | 2.21M | 1.90M | 1.64M | 1.24M | 1.27M | 1.67M | |||||||||||||||||
| Total Current Liabilities | 12.44M | 15.99M | 20.26M | 26.11M | 24.56M | 27.72M | 26.32M | 32.61M | 40.46M | 43.94M | 51.77M | 54.38M | 53.56M | 59.68M | 57.31M | 68.40M | 74.16M | 85.07M | 71.09M | 79.92M | |||||||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 0.01M | 0.00M | 7.16M | 6.90M | 6.70M | 6.10M | 5.62M | 5.07M | 5.14M | 4.75M | 4.74M | 4.32M | 5.20M | 4.70M | 4.31M | 3.99M | 4.11M | 3.81M | 3.35M | 3.46M | |||||||||||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||||||||||||
| Operating Leases | 3.32M | 3.07M | 2.82M | 2.56M | 2.30M | 2.02M | 1.74M | 1.46M | 48.18M | 47.55M | 46.71M | 45.87M | 45.13M | 44.57M | 43.94M | 43.33M | 49.14M | 42.05M | 47.85M | 47.19M | |||||||||||||||
| Non-Current Deferred Tax Liability | 0.45M | 9.80M | 9.75M | ||||||||||||||||||||||||||||||||
| Other Non-Current Liabilities | 0.20M | 0.51M | 0.83M | 1.77M | 2.33M | 2.89M | 3.24M | 4.93M | 5.93M | ||||||||||||||||||||||||||
| Total Non-Current Liabilities | 96.25M | 104.57M | 103.88M | 108.96M | 105.56M | 115.71M | 120.97M | 130.93M | 115.75M | 123.99M | |||||||||||||||||||||||||
| Total Liabilities | 15.77M | 19.07M | 30.24M | 35.57M | 33.51M | 35.85M | 33.68M | 39.14M | 93.79M | 96.25M | 103.22M | 104.77M | 104.39M | 109.79M | 107.33M | 118.05M | 123.86M | 134.17M | 120.68M | 129.92M | |||||||||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||||||||
| Common Equity | 193.59M | 331.94M | 303.04M | 386.17M | 351.37M | 316.33M | 280.33M | 254.12M | 547.75M | 539.11M | 874.93M | 830.76M | 832.98M | 1,324.81M | 1,254.00M | 1,171.53M | 1,072.17M | 992.08M | 1,280.65M | 1,191.96M | |||||||||||||||
| Liabilities and Shareholders Equity | 209.36M | 351.01M | 333.29M | 421.73M | 384.88M | 352.18M | 314.01M | 293.25M | 641.54M | 635.35M | 978.15M | 935.53M | 937.37M | 1,434.59M | 1,361.33M | 1,289.57M | 1,196.03M | 1,126.26M | 1,401.32M | 1,321.88M | |||||||||||||||
| Treasury Shares | |||||||||||||||||||||||||||||||||||
| Retained Earnings | -244.50M | -275.25M | -309.90M | -352.30M | -394.20M | -439.17M | -485.20M | -536.15M | -593.61M | -653.70M | -720.63M | -794.70M | -871.51M | -952.11M | -1048.88M | -1200.00M | -1300.00M | -1417.43M | -1545.27M | -1700.00M |